Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,661
Sort by:

Schistosomiasis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Schistosomiasis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Schistosomiasis pipelin...

February 2023 40 pages

Secondary Hyperparathyroidism Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Secondary Hyperparathyroidism Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Secondary...

February 2023 50 pages

Secondary (Hypogonadotropic) Hypogonadism Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Secondary (Hypogonadotropic) Hypogonadism Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of t...

February 2023 40 pages

Sedation Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Sedation Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Sedation pipeline candidate, d...

February 2023 40 pages

Severe Acute Respiratory Syndrome (SARS) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Severe Acute Respiratory Syndrome (SARS) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of th...

February 2023 160 pages

Short Bowel Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Short Bowel Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Short Bowel Syndro...

February 2023 90 pages

Sicca Syndrome (Sjogren) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Sicca Syndrome (Sjogren) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Sicca Syndrome...

February 2023 190 pages

Sickle Cell Disease with Vaso-Occlusive Crisis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Sickle Cell Disease with Vaso-Occlusive Crisis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each...

February 2023 50 pages

Sinusitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Sinusitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Sinusitis pipeline candidate,...

February 2023 180 pages

Smallpox Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Smallpox Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Smallpox pipeline candidate, d...

February 2023 40 pages

Spinal Muscular Atrophy (SMA) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Spinal Muscular Atrophy (SMA) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Spinal Mu...

February 2023 180 pages

Spinocerebellar Ataxia (SCA) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Spinocerebellar Ataxia (SCA) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Spinocereb...

February 2023 130 pages

Streptococcus pyogenes Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Streptococcus pyogenes Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Strep...

February 2023 40 pages

Synovial Sarcoma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Synovial Sarcoma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Synovial Sarcoma pipel...

February 2023 170 pages

Systemic Mastocytosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Systemic Mastocytosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Systemic Mastocyt...

February 2023 50 pages

Tetanus Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Tetanus Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Tetanus pipeline candidate, det...

February 2023 140 pages

Thromboembolism Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Thromboembolism Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Thromboembolism pipelin...

February 2023 140 pages

Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  202...

February 2023 40 pages

Tinea pedis (Athlete Foot) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Tinea pedis (Athlete Foot) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Tinea pedis...

February 2023 40 pages

Tinnitus Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Tinnitus Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Tinnitus pipeline candidate, d...

February 2023 40 pages

Tourette Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Tourette Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Tourette Syndrome pip...

February 2023 40 pages

Toxoplasmosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Toxoplasmosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Toxoplasmosis pipeline ca...

February 2023 40 pages

Trigeminal Neuralgia (Tic Douloureux) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Trigeminal Neuralgia (Tic Douloureux) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the T...

February 2023 70 pages

Tularaemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Tularaemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Tularaemia pipeline candidat...

February 2023 40 pages

Typhoid Fever Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Typhoid Fever Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Typhoid Fever pipeline ca...

February 2023 50 pages

Ureter Cancer Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Ureter Cancer Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Ureter Cancer pipeline ca...

February 2023 120 pages

Urinary Incontinence Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Urinary Incontinence Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Urinary Incontinen...

February 2023 90 pages

Usher Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Usher Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Usher Syndrome pipeline...

February 2023 70 pages

Uterine Leiomyoma (Uterine Fibroids) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Uterine Leiomyoma (Uterine Fibroids) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Ut...

February 2023 70 pages

Vaginal Cancer Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Vaginal Cancer Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Vaginal Cancer pipeline...

February 2023 130 pages

Vancomycin-Resistant Enterococcus Faecium Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Vancomycin-Resistant Enterococcus Faecium Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. Fo...

February 2023 100 pages

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  ...

February 2023 50 pages

Venous Leg Ulcers (Crural ulcer) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Venous Leg Ulcers (Crural ulcer) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Venous...

February 2023 70 pages

Ventilator Associated Pneumonia (VAP) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Ventilator Associated Pneumonia (VAP) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the V...

February 2023 150 pages

Ventricular Tachycardia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Ventricular Tachycardia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Ventricular Tac...

February 2023 50 pages

Viral Conjunctivitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Viral Conjunctivitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Viral Conjunctivit...

February 2023 50 pages

Vitiligo Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Vitiligo Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Vitiligo pipeline candidate, d...

February 2023 130 pages

Warts Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Warts Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Warts pipeline candidate, details...

February 2023 130 pages

Western Equine Encephalitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Western Equine Encephalitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Western Equ...

February 2023 40 pages

Wilson Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Wilson Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Wilson Disease pipeline...

February 2023 60 pages

Yellow Fever Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Yellow Fever Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Yellow Fever pipeline cand...

February 2023 100 pages

Cannabis Testing Market by Product Type (Instruments, Consumables, Software), Test Type (Heavy Metal Testing, Microbial Analysis, Potency Testing, Residual Screening, and Others), End User (Cannabis Cultivators/Growers, Cannabis Drug Manufacturers, and Others), and Region 2023-2028

US$ 2,499.00

The global cannabis testing market size reached US$ 1,269 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,619 Million by 2028, exhibiting a growth rate (CAGR) of 13.00%...

February 2023 143 pages

Health and Wellness Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

US$ 2,499.00

The global health and wellness market size reached US$ 3,481.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4,454.0 Billion by 2028, exhibiting a growth rate (CAGR) of...

February 2023 144 pages

Jet Lag Therapy Market by Product (Prescription Drugs, Melatonin, Herbal and Natural Products, Medical Devices, and Others), Application (Business Travelers, Cabin Crew, Athletes, Seasonal Travelers, and Others), Distribution Channel (Over the Counter, Online), End Users (Hospitals, Homecare, Speciality Clinics, and Others), and Region 2023-2028

US$ 2,499.00

The global jet lag therapy market size reached US$ 407.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 521.3 Million by 2028, exhibiting a growth rate (CAGR) of 4.40% d...

February 2023 145 pages

Laboratory Centrifuge Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

US$ 2,499.00

The global laboratory centrifuge market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.2 Billion by 2028, exhibiting a growth rate (CAGR) of 4.3%...

February 2023 148 pages

Photomedicine Technology Market by Technology (Laser, Polychromatic Polarized Light, Full Spectrum Light, Dichroic Lamps, Light Emitting Diodes, Photodynamic Therapy, Interventional Radiology), Application (Aesthetics and Dermatology, Dental Procedures, Oncology, Ophthalmology, Pain Management, Wound Healing, and Others), and Region 2023-2028

US$ 2,499.00

The global photomedicine technology market size reached US$ 449.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 624.5 Million by 2028, exhibiting a growth rate (CAGR) o...

February 2023 142 pages

Telehealth Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

US$ 2,499.00

The global telehealth market size reached US$ 15.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 49.8 Billion by 2028, exhibiting a growth rate (CAGR) of 21.6% during 2...

February 2023 147 pages

Filters

Search

Categories

808
26
203
153
138
134
125
90
65,562
803
720
776
123

Publishers

179
1
239
158
389
103
453
148
425
3
202
3
6
1,620
487
76
123
208
1,842
111
25
212
1,049
376
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
60
1,696
8
8,921
2,213
4,532
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
306
8
3
18
58
900
6
89
13
24
15
1,285
227
128
386
3
74
10
119
231
46
474
25
133
4

Regions

92
58
45
43
41
31
30
30
29
28
28
28
21
16
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
790
495
2
2
2
117
194
102
53
23
703
26
136
525
174
622
64,677

Price

Date

Pages

Offers

1
280
1
1